Our news

Biopharm International The document builds on key concepts outlined in ICH E8(R1) General Considerations for Clinical Studies. FDA announced the availability of the draft guidance, E6(R3) Good Clinical Practice (GCP) on June 5, 2023. Prepared by the International Council for Harmonisation (ICH), the GCP guideline provides a standard for facilitating a mutual acceptance of clinical trial data for […]

Biopharma Dive Many professionals in the life sciences industry are excited about the benefits decentralised clinical trials (DCTs) bring to the clinical research process and specifically to patients. The use of wearables, electronic consent forms, digital outcomes assessments, and other DCT technologies are transforming how we gather clinical data and interact with study participants. However, […]

Yoani Matsakis President of Telemedicine Technologies will be delivering an engaging speech at the upcoming “𝐇𝐀𝐂𝐑𝐎 [𝐇𝐞𝐥𝐥𝐞𝐧𝐢𝐜 𝐀𝐬𝐬𝐨𝐜𝐢𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐂𝐑𝐎𝐬] 𝐂𝐋𝐈𝐍𝐈𝐂𝐀𝐋 𝐓𝐑𝐈𝐀𝐋𝐒 𝐅𝐎𝐑𝐔𝐌 – 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬 𝐚𝐧𝐝 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞𝐬” 𝐨𝐧 𝐉𝐮𝐧𝐞 𝟖𝐭𝐡 at the prestigious Divani Caravel Hotel in Athens, Greece. Mr. Matsakis’s speech, titled “𝙏𝙝𝙚 𝙀𝙐𝘾𝙍𝙊𝙁 𝙂𝘿𝙋𝙍 𝘾𝙤𝙙𝙚 𝙤𝙛 𝘾𝙤𝙣𝙙𝙪𝙘𝙩 𝙛𝙤𝙧 𝘾𝙡𝙞𝙣𝙞𝙘𝙖𝙡 𝙍𝙚𝙨𝙚𝙖𝙧𝙘𝙝, 𝙬𝙝𝙚𝙧𝙚 𝙖𝙧𝙚 𝙬𝙚, 𝙖𝙣𝙙 𝙬𝙝𝙖𝙩 𝙘𝙖𝙣 […]

Wednesday may 24 TELEMEDICINE TECHNOLOGIES will be present at SantExpo on the OVHcloud stand as a partner of the “Open Trusted Cloud” program. Our president Yoani Matsakis will be representing Telemedicine Technologies, and wil intervene next to Mathieu Godart, CTO and co-founder of SÊMEIA and Emmanuel MEYRIEUX, Client Security manager at OVHcloud. Throughout the day you […]